About

Hypertension is the most common modifiable risk factor for cardiovascular disease and death, and lowering blood pressure with antihypertensive drugs reduces target organ damage and prevents cardiovascular disease outcomes.

Most hypertensive patients will need a combination of antihypertensive agents to achieve the therapeutic goals. Recent guidelines recommend initiating treatment with two drugs in those patients with a systolic blood pressure >20 mmHg and/or a diastolic blood pressure >10 mmHg above the goals, and in those patients with high cardiovascular risk. In addition, approximately 25% of patients will require three antihypertensive agents to achieve the therapeutic targets.

Articles

APSC Consensus on Optimising CV Outcomes in T2D

Published:

19 April 2021

Citation:

European Cardiology Review 2021;16:e14.

Renin–Angiotensin–Aldosterone System and COVID-19

Published:

09 March 2021

Citation:

European Cardiology Review 2021;16:e07.

Balloon Pulmonary Angioplasty: State of the Art

Published:

15 February 2021

Citation:

Interventional Cardiology Review 2021;16:e02.

Nocturnal Blood Pressure and Sleep Quality in Hypertension Management

Published:

24 August 2020

Citation:

European Cardiology Review 2020;15:e60.